CASI Pharmaceuticals, Inc.
CASI
$0.94
$0.010.88%
NASDAQ
| 09/30/2025 | 03/31/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.69M | 12.70M | 16.09M | 16.09M | 20.81M |
| Total Receivables | 2.61M | 7.60M | 15.35M | 15.35M | 11.14M |
| Inventory | 2.61M | 4.15M | 5.25M | 5.25M | 12.93M |
| Prepaid Expenses | 2.01M | 2.71M | 2.89M | 2.89M | 2.27M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 11.92M | 27.16M | 39.58M | 39.58M | 47.15M |
|
|
|||||
| Total Current Assets | 11.92M | 27.16M | 39.58M | 39.58M | 47.15M |
| Net Property, Plant & Equipment | 9.95M | 10.92M | 11.36M | 11.36M | 12.40M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 224.00K | 233.00K | 238.00K | 238.00K | 1.12M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 660.00K | 590.00K | 587.00K | 587.00K | 702.00K |
| Total Assets | 24.46M | 40.82M | 53.67M | 53.67M | 63.62M |
|
|
|||||
| Total Accounts Payable | 560.00K | 1.20M | 2.72M | 2.72M | 1.76M |
| Total Accrued Expenses | 20.01M | 14.03M | 8.47M | 8.47M | 12.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.86M | 18.49M | 19.61M | 19.61M | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 5.66M | 5.66M | -- |
| Total Other Current Liabilities | -- | -- | 5.66M | 5.66M | -- |
| Total Current Liabilities | 39.42M | 33.71M | 36.45M | 36.45M | 14.74M |
|
|
|||||
| Total Current Liabilities | 39.42M | 33.71M | 36.45M | 36.45M | 14.74M |
| Long-Term Debt | -- | -- | -- | -- | 19.12M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 2.54M | 2.54M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.63M | 15.18M | 12.84M | 12.84M | 15.91M |
| Total Liabilities | 53.05M | 48.89M | 51.82M | 51.82M | 49.77M |
|
|
|||||
| Common Stock & APIC | 721.24M | 714.59M | 713.30M | 713.30M | 712.60M |
| Retained Earnings | -735.09M | -710.83M | -700.08M | -700.08M | -685.71M |
| Treasury Stock & Other | -14.74M | -11.83M | -11.38M | -11.38M | -13.05M |
| Total Common Equity | -28.59M | -8.07M | 1.85M | 1.85M | 13.85M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -28.59M | -8.07M | 1.85M | 1.85M | 13.85M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -28.59M | -8.07M | 1.85M | 1.85M | 13.85M |
|
|
|||||